The Trump Administration earlier this week made moves to dismiss a lawsuit that would curtail mifepristone access, but as healthcare attorney and founder of Nelson Hardiman Harry Nelson explained to ForbesWomen editor Maggie McGrath in this Forbes Newsroom segment, there's more to the administration's actions than meets the eye.<br />
